Scientists have developed a new tool that mimics how the novel coronavirus which causes COVID-19 enters and infects cells, an advance that could potentially speed up the search for treatments against the deadly disease.
Search
Health and Lifestyle
New Delhi, Sept 19: Scientists examined the effectiveness of common household fabrics used in homemade masks in blocking droplets generated by coughing and sneezing, and have found that they are considerably protective even as a single layer.
London, Sept 18: Researchers have created a 90-minute high speed COVID-19 test which does not require a laboratory and can be performed in cartridges smaller than a mobile phone with high accuracy.
Ludhiana, Sept 18: DMCH Cancer Care Centre in collaboration with American Oncology Institute recently started a new diagnostic service (PSMA-PET Scan) in treating various prostate cancer.
Vaccine candidates for COVID-19 should elicit a broad immune response that includes antibodies, and the body's helper and killer T cells, according to a study which says weak or uncoordinated immunity may lead to a poor disease outcome.
New Delhi, Sept 17: Union Health Minister Harsh Vardhan on Thursday said that the coronavirus vaccine will be made available in the country by the start of next year. The remarks come at a time when India is recording more than 50 lakh cases and people are awaiting the vaccine with bated breath.
Beirut, Sept 15: Once herd immunity is attained, the novel coronavirus may follow suit and become a seasonal virus in countries with temperate climates, but until that time, COVID-19 will continue to spread across the seasons, a new study says.
New Delhi, Sept 13: A group of scientists in India is working on genomic sequences of SARS-CoV-2 around the World, including India, to identify genetic variability and potential molecular targets in virus and human to find the best possible answer to combat the COVID-19 virus.
Vaccine maker Bharat Biotech on Friday announced that the animal trials of its Covid-19 vaccine candidate Covaxin were successful. It said the results demonstrated the protective efficacy of the vaccine in a live viral challenge model.
New Delhi, Sept 12: Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in the backdrop of pharma giant AstraZeneca pausing the trials in other countries. In an order, a copy of which has been accessed by PTI, DCGI Dr V G Somani on Friday also directed